Indapta
indapta.comLocations
San Francisco, CA, USA · Houston, TX, USA
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2017
Indapta's allogeneic G-NK cells have highly potent ADCC activity, making them the ideal therapy to combine with IgG1 monoclonal antibodies, ADCs, or innate immune cell engager molecules.
Something looks off?Open jobs at Indapta
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.